<SEC-DOCUMENT>0001193125-19-009757.txt : 20190115
<SEC-HEADER>0001193125-19-009757.hdr.sgml : 20190115
<ACCEPTANCE-DATETIME>20190115160535
ACCESSION NUMBER:		0001193125-19-009757
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20190114
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20190115
DATE AS OF CHANGE:		20190115

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Tilray, Inc.
		CENTRAL INDEX KEY:			0001731348
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38594
		FILM NUMBER:		19527186

	BUSINESS ADDRESS:	
		STREET 1:		1920 EASTLAKE AVENUE E.
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98102
		BUSINESS PHONE:		2064329325

	MAIL ADDRESS:	
		STREET 1:		1920 EASTLAKE AVENUE E.
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98102
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d634385d8k.htm
<DESCRIPTION>8-K
<TEXT>
<HTML><HEAD>
<TITLE>8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT
STYLE="white-space:nowrap">8-K</FONT> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT
REPORT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PURSUANT TO SECTION 13 OR 15(d) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>OF THE SECURITIES EXCHANGE ACT OF 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Date of Report (Date of earliest event reported): January&nbsp;14, 2019 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>Tilray, Inc. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact
name of registrant as specified in its charter) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">001-38594</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">82-4310622</FONT></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>of incorporation)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Commission</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>File Number)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(IRS Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>1100 Maughan Road </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Nanaimo, BC, Canada, V9XIJ2 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address of principal executive offices and zip code) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Registrant&#146;s telephone number, including area code: <FONT STYLE="white-space:nowrap">(844)&nbsp;845-7291</FONT> </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <FONT STYLE="white-space:nowrap">8-K</FONT> filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions (see General Instruction&nbsp;A.2. below): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Soliciting material pursuant to Rule <FONT STYLE="white-space:nowrap">14a-12</FONT> under the Exchange Act (17
CFR <FONT STYLE="white-space:nowrap">240.14a-12)</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">Pre-commencement</FONT> communications pursuant to Rule <FONT
STYLE="white-space:nowrap">14d-2(b)</FONT> under the Exchange Act (17 CFR <FONT STYLE="white-space:nowrap">240.14d-2(b))</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">Pre-commencement</FONT> communications pursuant to Rule <FONT
STYLE="white-space:nowrap">13e-4(c)</FONT> under the Exchange Act (17 CFR <FONT STYLE="white-space:nowrap">240.13e-4(c))</FONT> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this
chapter) or Rule <FONT STYLE="white-space:nowrap">12b-2</FONT> of the Securities Exchange Act of 1934 <FONT STYLE="white-space:nowrap">(&#167;240.12b-2</FONT> of this chapter). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Emerging growth company&nbsp;&nbsp;&#9746; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an
emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&nbsp;13(a) of the Exchange
Act.&nbsp;&nbsp;&#9744; </P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;1.01. Entry into a Material Definitive Agreement. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On January&nbsp;14, 2019, Tilray, Inc. (the &#147;<U>Company</U>&#148;), a global pioneer in cannabis production and distribution, entered into a Profit
Participation Agreement (the &#147;<U>Profit Participation Agreement</U>&#148;) and a Payment Agreement (the &#147;<U>Payment Agreement</U>&#148;) with ABG Intermediate Holdings&nbsp;2, LLC (&#147;<U>ABG</U>&#148;), pursuant to which the Company
purchased from ABG participation rights in up to 49% of the net (i.e., post-expense) royalties from cannabis products bearing brands currently within the ABG portfolio (ratably based on the portion of the aggregate amount of consideration (as
described below) received by ABG) that ABG receives from the exploitation of certain ABG brands in connection with the development, marketing and sale of cannabis-related products. As consideration for such participation rights, the Company
(a)&nbsp;paid $20,000,000 in cash to ABG and issued 840,107 shares of Class&nbsp;2 Common Stock of the Company to ABG (valued at $66,666,666 in aggregate based on the &#147;Opening Stock Value&#148; described below), (b) has agreed to pay an
additional $13,333,333 in cash to ABG not later than 45&nbsp;days after the date of the Payment Agreement, (c)&nbsp;has agreed to pay an additional 840,107 shares of Class&nbsp;2 Common Stock of the Company to ABG with an aggregate value of
$66,666,667 based on the Opening Stock Value, subject to certain triggers pertaining to the regulatory status of cannabidiol in the United States, and (d)&nbsp;has agreed to pay further additional consideration with an aggregate value of $83,333,333
in a combination, at ABG&#146;s election, of up to $16,666,667 in cash and the remainder of such value in shares of Class&nbsp;2 Common Stock of the Company (based on a <FONT STYLE="white-space:nowrap">15-trading</FONT> day volume weighted average
price of such shares on the date of payment of such further additional consideration) subject to certain triggers pertaining to the regulatory status of tetrahydrocannibinol in the United States or the receipt of $5,000,000 in distributions to the
Company from the Profit Participation Agreement derived from cannabis products that contain tetrahydrocannibinol outside of the United States, in accordance with the terms and conditions set forth in, the Payment Agreement. For the purposes of the
transaction, the parties agreed that the Company&#146;s Class&nbsp;2 Common Stock &#147;Opening Stock Value&#148; is the average of the volume weighted average trading price of such shares for the two
<FONT STYLE="white-space:nowrap">15-trading</FONT> day periods ended on January&nbsp;10 and January&nbsp;11, 2019. That average is $79.355 per Class&nbsp;2 Common Stock of the Company. The shares of Class&nbsp;2 Common Stock of the Company that were
issued and are to be issued in connection with the transactions contemplated by the Profit Participation Agreement and the Payment Agreement have not been registered with the Securities and Exchange Commission and are subject to certain transfer
restrictions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the Profit Participation Agreement, the Company will, among other things and in addition to the participation rights, have the
opportunity to (a)&nbsp;license and develop cannabis products bearing brands currently within the ABG portfolio, and (b)&nbsp;supply active cannabinoid ingredients, including tetrahydrocannabinol and cannabidiol, for products created and sold
pursuant to licenses entered into by ABG with the Company or third parties to develop branded cannabis products. In the event ABG acquires additional brands after entering into the Profit Participation Agreement, the Company will also have the right
to purchase participation rights in the net (i.e., post-expense) royalties from cannabis products bearing such brands, to be negotiated with ABG in each instance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing descriptions of the transactions contemplated by the Profit Participation Agreement and the Payment Agreement do not purport to be complete and
are subject to, and are </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
qualified in their entirety by, the full text of the Profit Participation Agreement and the Payment Agreement, which will be filed as exhibits to the Company&#146;s Annual Report on Form <FONT
STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2018. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A copy of the press release announcing the Company&#146;s entry into
the Profit Participation Agreement and the Payment Agreement is filed herewith as Exhibit&nbsp;99.1 and is incorporated herein by reference. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;3.02 Unregistered Sales of Equity Securities. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the consummation of the transactions contemplated by the Profit Participation Agreement and the Payment Agreement, the Company has issued
840,107 shares of Class&nbsp;2 Common Stock of the Company, and has agreed to issue additional shares of Class&nbsp;2 Common Stock of the Company, to ABG, each in accordance with the terms and conditions set forth in the Payment Agreement. The
information contained in (or incorporated by reference into) Item 1.01 of this Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> is hereby incorporated by reference into this Item&nbsp;3.02. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;9.01 Financial Statements and Exhibits. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(d)
Exhibits. </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center">Exhibit<BR>Number</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Description</P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="d634385dex991.htm">Press Release issued January&nbsp;15, 2019</A></TD></TR>
</TABLE>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">TILRAY, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By: <U>/s/ Brendan
Kennedy&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Name: Brendan Kennedy</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Title: President and Chief Executive Officer</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: January&nbsp;15, 2019 </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d634385dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit&nbsp;99.1 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g634385g35t40.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Tilray<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> and Authentic Brands Group Sign Global Revenue Sharing
Agreement to Develop and Market Consumer Cannabis Brands </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Agreement leverages Tilray&#146;s cannabis expertise and ABG&#146;s
extensive portfolio of iconic brands that span the entertainment, fashion, streetwear, active, home and health and wellness sectors. </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>NANAIMO,
B.C. </B>&#150; Today, Tilray, Inc. (NASDAQ: TLRY), a global pioneer in cannabis production and distribution, and Authentic Brands Group (ABG), an owner of a portfolio of global lifestyle and entertainment brands, announced that they have signed a
long-term revenue sharing agreement to market and distribute a portfolio of consumer cannabis products within ABG&#146;s brand portfolio in jurisdictions where regulations permit. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As the owner of more than 50&nbsp;brands, ABG builds value by partnering with an expansive network of <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">best-in-class</FONT></FONT> manufacturers, operators and retailers. With a global retail footprint of over 100,000 points of sale and more than 4,500 branded freestanding stores and <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">shop-in-shops,</FONT></FONT> ABG&#146;s portfolio generates approximately US$9&nbsp;billion in retail sales annually. Reaching nearly 250&nbsp;million social media followers across key digital platforms, ABG&#146;s robust
marketing arm drives growth and engagement for its portfolio, including connecting its brands with over 150&nbsp;million targeted followers through Winston, its proprietary micro-influencer network. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the terms of the agreement: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The parties will leverage ABG&#146;s portfolio of brands to develop, market and distribute consumer cannabis
products across the world, as and where legal, with an immediate focus on opportunities, including CBD, in Canada and the U.S. subject to applicable and brand appropriate regulations. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Tilray will be the preferred supplier of active cannabinoid ingredients for such products. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Tilray will initially pay to ABG US$100&nbsp;million and up to US$250&nbsp;million in cash and stock, subject to
the achievement of certain commercial and/or regulatory milestones. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Tilray will have the right to receive up to 49% of the net revenue from cannabis products bearing ABG brands,
with a guaranteed minimum payment of up to US$10&nbsp;million annually for 10&nbsp;years, subject to certain commercial and/or regulatory milestones. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Through this agreement, ABG and Tilray join forces at the intersection of science and brand to connect consumers with innovative health and wellness products
suited to their many lifestyle needs. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tilray | Nanaimo, BC | www.tilray.com </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g634385g35t40.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;We are thrilled to partner with ABG, a global leader known for expertly managing and marketing an owned portfolio of
iconic brands,&#148; said Brendan Kennedy, Tilray President and CEO. &#147;As we work to expand Tilray&#146;s global presence, this agreement leverages our complementary strengths and will be accretive to our shareholders as we reach new consumers
across the entertainment, fashion, beauty, home and health and wellness sectors. We look forward to working with ABG to bring unique and sought-after branded cannabis products to the marketplace.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Daniel W. Dienst, ABG Executive Vice Chairman, said, &#147;Tilray&#146;s unyielding focus on science, product quality, operational excellence and innovation
has allowed them to quickly emerge as a leader in the cannabis industry. We see extraordinary potential for cannabis in the fast-growing health and wellness category &#150; particularly for CBD products in the United States and around the world
&#150; and are excited about this long-term partnership.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tilray&#146;s financial advisor on the transaction was BofA Merrill Lynch. Authentic
Brands Group&#146;s legal advisor on the transaction was Paul, Weiss, Rifkind, Wharton&nbsp;&amp; Garrison LLP. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Tilray<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tilray (NASDAQ:TLRY) is a global pioneer in the research, cultivation, production and
distribution of cannabis and cannabinoids currently serving tens of thousands of patients and consumers in twelve countries spanning five continents. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Authentic Brands Group </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Authentic Brands Group
(ABG) is a brand development and marketing company, which owns a portfolio of global entertainment and lifestyle brands. Headquartered in New York City, ABG&#146;s shareholders include Leonard Green&nbsp;&amp; Partners LP, General Atlantic LP, Lion
Capital LLP, its management, and employees. ABG manages, elevates, and builds the long-term value of more than 50 consumer brands and properties by partnering with
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">best-in-class</FONT></FONT> manufacturers, wholesalers, and retailers. Its brands have a global retail footprint in more than 100,000 points of sale across the luxury, specialty,
department store, <FONT STYLE="white-space:nowrap">mid-tier,</FONT> mass, and <FONT STYLE="white-space:nowrap">e-commerce</FONT> channels and more than 4,500 branded freestanding stores and <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">shop-in-shops</FONT></FONT> around the world. ABG is committed to transforming brands by delivering compelling product, content, business, and immersive brand experiences. It creates and activates original marketing
strategies to drive the success of its brands across all consumer touchpoints, platforms, and emerging media. ABG&#146;s portfolio of iconic and world-renowned brands includes Marilyn Monroe<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>,
Mini Marilyn<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Elvis Presley<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Muhammad Ali<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Shaquille O&#146;Neal<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Dr.&nbsp;J<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Greg Norman<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Neil Lane<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Thalia<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Michael Jackson<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> (managed brand), Nautica<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, A&eacute;ropostale<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Juicy Couture<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Vince Camuto<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Herve Leger<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Judith Leiber<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Frederick&#146;s of Hollywood<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Nine West<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Frye<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Jones New
York<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Louise et Cie<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Sole Society<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Enzo Angiolini<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, CC Corso Como<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Hickey Freeman<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Hart Schaffner Marx<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Adrienne Vittadini<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Taryn Rose<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Bandolino<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Misook<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, 1.STATE<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>,
CeCe<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Chaus<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Spyder<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>,
Tretorn<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Tapout<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Prince<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Airwalk<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Vision Street Wear<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Above The Rim<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Hind<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Thomasville<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Drexel<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, and
Henredon<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>. For more information, please visit <U><FONT STYLE="white-space:nowrap">ABG-NYC.com</FONT></U>. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tilray | Nanaimo, BC | www.tilray.com </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g634385g35t40.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Cautionary Note Regarding Forward-looking Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This press release contains &#147;forward-looking statements&#148; within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and
&#147;forward-looking information&#148; within the meaning of Canadian securities laws, or collectively, forward-looking statements. Forward-looking statements in this press release may be identified by the use of words such as, &#147;may&#148;,
&#147;would&#148;, &#147;could&#148;, &#147;will&#148;, &#147;likely&#148;, &#147;expect&#148;, &#147;anticipate&#148;, &#147;believe, &#147;intend&#148;, &#147;plan&#148;, &#147;forecast&#148;, &#147;project&#148;, &#147;estimate&#148;,
&#147;outlook&#148; and other similar expressions and include statements relating to ABG projected retail sales and the global success of the Tilray and ABG agreement. Forward-looking statements are not a guarantee of future performance and are
based upon a number of estimates and assumptions of management in light of management&#146;s experience and perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and
reasonable in the circumstances, including assumptions in respect of current and future market conditions, the current and future regulatory environment and future approvals and permits. Actual results, performance or achievement could differ
materially from that expressed in, or implied by, any forward-looking statements in this press release, and, accordingly, you should not place undue reliance on any such forward-looking statements and they are not guarantees of future results.
Forward-looking statements involve significant risks, assumptions, uncertainties and other factors that may cause actual future results or anticipated events to differ materially from those expressed or implied in any forward-looking statements.
Please see the heading &#147;Risk Factors&#148; in Tilray&#146;s Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q,</FONT> which was filed with the Securities and Exchange Commission and Canadian securities regulators on
November&nbsp;14, 2018, for a discussion of the material risk factors that could cause actual results to differ materially from the forward-looking information. Tilray does not undertake to update any forward-looking statements that are included
herein, except in accordance with applicable securities laws. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For further information: </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Tilray: </U></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Media: Chrissy Roebuck, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">1-833-206-8161,</FONT></FONT></FONT> news@tilray.com </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Investors: Katie Turner, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">+1-646-277-1228,</FONT></FONT></FONT> Katie.turner@icrinc.com </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Authentic Brands Group: </U></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Corporate Communications: Haley Steinberg, 646.612.7439,
<FONT STYLE="white-space:nowrap">hsteinberg@abg-nyc.com</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Health and Wellness, Marketing&nbsp;&amp; PR: Alli Good, 646.779.5336,
<FONT STYLE="white-space:nowrap">agood@abg-nyc.com</FONT> </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tilray | Nanaimo, BC | www.tilray.com </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g634385g35t40.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g634385g35t40.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  _ J,# 2(  A$! Q$!_\0
M'P   @(" P$! 0            H("0<+ 04&! ,"_\0 7!    8! P(# P8#
M$0L)"0   0(#! 4&!P ($1(A"1,Q%!5!%A<B46%Q"B,X&28G,C8W.5=U=G>!
MD:&UM_ 8&B0E1D>7ML'5X3525598>);1UD)%8F:'E;.TU/_$ !T! 0 !!0$!
M 0             ! @4&!P@) P3_Q !#$0 ! P,# @,$!0D' P4    ! @,$
M!081  <A$C$($T$446%Q(H&1L? 5%R,R-Z'!T>$6)%5VE+7Q&'74)4*$MM+_
MV@ , P$  A$#$0 _ '^-&C1IIHT:-&FFC70S=JJ]:%N%CLD!7Q> J+0)N8CH
MH70(]'G"W!^X0\\$?-3\WRNKR_,)U\=9><&[L=U.(=F6#;CGS-4Z6(J54:@F
MSCVXI*3UOLCPBA8*FU5@HHF,G8IYTF*#-L4Q46Z)'4G(+-(M@^>-]9OOMWN9
M=W_9[G\WY;=>SMC>;#X[H+9RHYKN,J,DY.M&U>$34 A%G1Q-[;8YL44W=@FU
M7+]<J38K)DSRVV;3E7$MUPNF'!9RE4I37F>8]@$,LH*VPM200IU76 VDIR"I
M:0<7N*YXU!2TV&Q*F.X4F,'/+Z&<D%UU80X4 D%+:>G+B@K&$H41M)F.1<?2
M;QM'1MZILA(/%01:,6-GA';QTL8!$J+9L@^4775, "()I$,<0 1 . '7LM)-
M>!ALMC,$8DLWB>YFKK8UBD&4K2=H-:EVA0.J]E".8::RH5NLF'(R!R/X.MN/
MTR=:8VR61Y3EHAR#6^U'<2VSE31:32S='(M710;V=FF4B!91N8?*:V5@W)P4
MK5\)?+>HI!T,9$%$@*FW79>9@EQUZUZ%?+=@-UD2ZVY3US@E;*&&U+;6I*XB
M%!]T&3T-O.I:)"U-QI"L!*$%S,Z!1;CK5G.7NY23%H[<Y$(J2ZIYP)<0E2)2
MD%EHB.5.--J= *$K?CIZB5K#<KM&C1K]VOR:-&C1IIHT:-&FFC1HT:::-&C1
MIIHT:-&FFC1HT:::-&C1IIHT:-&FFC1HT:::-&C1IIHT:-&FFC1HT:::-&C1
MIIHT:-&FFC1HT:::-&C1IIHT:-&FFC1HT:::-&C1IIJ+N]+-EIVZ;8LKYHI3
M"#D[118J&?1+"R-WSJ$<*R-I@H18K]"-?QCU1,K63743!!\W,"Y$C&,8@&3.
MNO\ F[.[3O\ H?8$[?#Y.7OD?XOG#^'Q#X?S!>/XI_Y FXS][U7_ *PJAI([
MMV[  CV[<\<\]P$/CV_MQP.NV_#3M[95W676:A<MN4ZL38]T2H;,B6AQ3C<5
M%)HSR&4]#J!Y:77WG "DGJ<5SV&O/7Q<;H[@V/N!0*9:5UU2A4^39T2>_%@N
M-(:=F+K=<CKD+"VEJ+BF8S#9.0.EL#'?-U7YNSNT]/F]P)\/\G+WVY^O]$/T
M_P"&K=O#%WDY\WG1&5+AE2MX[KM2ILG UFMJ4N&L;!S+6%VT<RDX#IS-6>=1
M.VBHY2& $4$$%!6DP.=8Q2>7I-T1 I1,8.  .K[P#N(AQW[!Z<\CP(^H:>!\
M-K#B6!-EV)8:4;DBYJQP2V4+D=<02,G*74 G"^VF/TBDI%UXT-%K@H/XKW:)
M1$ +VN'B(L[;BQ[&0:):=(@5ZN52+3J?)CMN>TQF&#[;/D-!;JTG]&PW"60E
M13[<DC"L$6OPL7WNMN)N,Z+AO:NU*V[<HTRIU.))=:,25(D@4ZFQ7RAA"L^;
M(>J" 5I"C3E Y3U)/:>(/GW,&V/;Q(YGP]!U"PR%6LU>0M;"XQLQ),$:G-N%
M(=62;%A9R#<I.F<V\A"G.HNNA[&X=&.D42%4+0M^;L[M._Z'V ^WP^3E[Y_D
M^</X?$/AIDFU,*)NWVU6&-@WR$O1LXXRE&L+)J)_0!O8XE=.+D3)<F,DYC'Y
MF[OH$1.@[9](_3)I"&>@I2K3LU6)UL=C.5R7DZ_,-%"B51K*PSY>.D6ZA1 !
MZDG;95,0$/4OH #JS^&^T;%NVBW'1[JM.FSKBMVK@/.3F743!!FH*&F'D>8V
M>N'-A3FW,IZFPXTVK! "K]XL+XW(LBOVI7K+O6K4^U;IH:O(9IS["X)J-/=0
MZ[)9<+3@\N=3ZA3G6>E92Z6I#B,I*L7*_F[.[3GCYO<"<]@_4Y>^W/\ ]0_3
M_A_'9AX9'B(9GWG9%R=4<G5K'$'&TNE1-CBUZ3%V)@\</7\[[L52>GFK-.HJ
M-2M_IIE0104!7Z1E3$^AI20. #D0^[ZQ[AR/;@>0^'Q[CZAJ^;P#N!S?GSO_
M )JJY]_ZKC<<_:'U_=QSQK8N\>U6W=!VSNVKT>TJ33ZE!A17(DV.VZEYAQ=3
M@,J4V5/*&5-N.(.4GA1'?G6J-AMZ-T[EW=LBAUV]ZW5*34*A,:FP)3K"F)+;
M=(J#Z$.A+"%$)>:;<&% ]21Z<%GF5GX*"! TW-1,.#D5 ;#*R3./!P*0%%4$
M!=K(@J*8'(*@)]0D Y1-QU!SU)+[15#E33NE34.<0*4A+'#F.8P^A2E*\$1$
M>!X  $>VJ OP@  &%VN<E W$SECCGZQCZ+Z?[>/NTMEP4! 0  -\!+SR @(^
M@AWY[AZ<_P _.M([:^&V-N!9=)NQR[WZ4NIJJ"3!10VYB&#!J4NGI/M"JM%4
MYY@C>:?T*.@K*!U=(4>B=VO%E*VQO^MV2W8T>M-T=-+4*BNXG("Y J-)@5-0
M,4466ELM&861A]SK#8</1U%"=C@<3+MSF:KIE.JB86SCI!PD4QR#Y*W050@+
MIE$2GZ"JD!0H< H7JZ@H"WJ^(5OUV79-2IUIH^ ;)3[&BZDL>7]G4KZT96>+
M:J)INVKUF.1UPB;'#G7;I3$2+A<A2N&KYDX<,7:1RP6\)/>9D?&6X&DX(LMI
MF)[$>6I(]5:0$R_=2:%2N#Q!4]<EJT+I90T4C)22*4++1[4R;!VE(I/3MQ>,
MD51NN\7O$T5DK9/D*>7:IJ3V)'D+D>O//**9PV!C)-XJPH)K"'F)MW=<E9(7
M"93 111LU.<#"B02VZ#84+:K=JB6?>],H]WV[=*H4>).D1%M*2BH2EP(DYE(
M=4["DQ*@GRI\4OR&'(BBX"M:H[K5TJ.Y50WGV1N&_-NZO7K&NFS4U"5-IT6<
MV\E;E*AMU*=3GR64LU")-I:O.ITP1HLEN:@-$(;3*9>IS'QV=V?[7V!/CV^3
ME[Y#CX#^B$'</CQ]_IJSGP^-W.^'>9)/+C:*EA2AX,KLB,;*6=E4[JI/6V80
M*51U7::1]?E6*9V2:B0S$^\0>,HPZR35%E(/171:J>5&K2]XME8I5?1%Q.VZ
MQ0U7AFX%$P*2D_)M8I@7I#D>D7+I,Q^/0A3"(< (Z?>H=2QWM-V\Q%;;G;PF
M/L*X\7=2T@5,""HSKD6O*V2?<E$Q16D)9TE(R[L1-YCE\[4 !ZCE#6R/$#0M
MN[!HM+I-LV/0Q=%TO/1X3Z8SLAV!#8\E#\EAE;JT+F/O26(T(.(6C)D.I2IQ
MA .IO##<>Z>Y=P5BN7;N)<2K.LZ.Q)GQE2VHS-3GR0\Y&B2)"&6UMP(T>)(F
M5 M.MK($9E2@U)<(S++3$1 L%Y6<E(Z&C&I>MU(RSYM',&Q/^<N\>*HMT2__
M !**%#[=8Z@\[X0L\F6%K>9,5V"8.H"2<5"9!J4K)**CT\)IL6,NNY4/](H=
M)$C#R(!QR/&DE]WN\?*V[_(LO:;G-23.CH2#H*%C9!ZN2MU6#*J)&('CTS%:
MR%A7:E35F9QVDJ[<O#J)MS-XY)JT0B,0I$SD43*4ATS =-1/Z"B1@'DIB'+P
M8IR" &*8H@8HE 0'L Z_%0O"&[)I##]P7<NG5B0PEQR% I;<R+3W5I!$=V2[
M.85-<;*NEXLHCMA:5H9<>0$NKN%Q^.9B+7)$:V+'15:%&D+::J-2K#L"94VF
MU])DLQ&:=)3!:> *HX?<DO%LH6^TRX5,(V(U_;WUU49I+&,K5X>] T.I77EU
MAY*=JPOTP$Z3::80\O!RGL3H0\A5TQ?@X9 ?VHC5Z*7LBRTN4_&)WV87R#:<
M7Y(Q%@JNW.GR2D9,1JU>O2J8F I5FSY@Z)D($7\7),U$)",D$!%!ZQ<(KIB'
M6)2R2\%_>K=,G)V?;-E:PO;/,TZOEM>,[)-O%'DVYJS-TUC)NJ2#YR<[J3]P
MK/8U["N'"BSM.,<O62RQVT<R*GX?QY<'1A([$&XJ)8$0EC2;G%-Q>(IE)[>S
M<,WUBIZ[L2% 55V*K&Q,2+*B8YD'K=OSY:")2XKMY9]%M'=:3M7N-;M$N!NI
MY51JPZPL+2\J*J9!>9="T+5#J+#2XSL5[S51JBE+;3B4B27\TW1ONOWSLM$W
MGVINJX+9>I'2FO4)F2VI"HZ9J(51CR62VZVF=29#S<MJ8QY2)E*4XX\VOJBA
MBVS89N#N6Z';+2<S7Z-KL39[')6YF^8U5K(,X1).!M$K"-#-D)22EWI#J-6*
M2C@57RH&7,H9,J9!*0LQ=5B>#W^03BG]W<D_U@6'[]6=ZT/N+3X=*OZ\Z93H
M[<2!3[GK<.'%:!#4>+'J,AIAEL$DA#;:4H2"2< <G72>UM2GUG;6P:M5)3LV
MI5.SK<GSYCY!>E3)=)B/R9#I2$I+CSJUN+(2!U*. !QK">XG,K/ 6(+;DYQ%
MC8'\,C'L*U6$W8,G%JMUADV<#5JVV<BBY,DK+S<BS;&5(V<'00,LX!%0$3%U
M\.VO-I<_XHB[ZZ@!J%E0F++4;S2U'P23BG7>GSCV L5></?9V@N3-G3,KENN
M+9 5V3MJOY904 -0SW?VS(-\W*X(Q'BS%[C,Z&$54-R.4*8WN%>I319^120K
M>(VLC-V0JD<51C.#+6CW8*#AR\38,EDTB$2.LG\>V&X9(H&[W+E&RMB5SA&+
MW01YLTX]JSB[5^]L5L@4QC%P.5083-;!-BD]L;!6(M+N.602=$%@[=#YB:Y5
M!P_''Q[]QV]V,Y[<]NVL[SS\.WU\=SZ>['O/V34QEFQ?(68=P^+%:\E%I8+F
M\?1#>:))'=J60MWII+6HNJQ,S;EC!CCG]B*F1R]!R4//$Z(_B@_13-"Z>YQM
MMZ^3Z0MG&#G&8!M/O$X+%70O2=.]P^Z?8_+%(Q%/>'O#V\#@8/9_9.!\[4>,
M RL?![W]\M/EG:#"QVA3 ]\K<6Y5(DYG*HWQP:OO9B+3.)3/6L?,M5(^0.W!
M0&;@4TUQ(8X!K]HN8C;+XEM@)!.T)4M!V?LZ[<%62I'",!/V'+?OJ(A9%5(Q
MR-I1W$M5I C%42.0:%!84P(/.A R>/\ V@]_4A//KZD\?5QZ ?CZD?O[>GI^
M#KI\^[G]U6!X^<MLGMOQK*8^;7B&J%?FDLXN49J52M=K:56IR#V"+C]4L:9\
MXDH]:2; _=!&D56X6<@@)C2:P[:MPMB>SJ6;,24?&K%JU9'K[JHY.5OZLL[5
M5<%?H/6ZM4KGNU)JB1LHBL"CH7)ECIBFEY74? 7B1_DT%_AHV^_SYEI@:GMI
MQTC@9R1GGTZ?CCW_ &Z8/O)^S^6L![;,U+Y]QF?(#FO)5A4EXR/3_=:,B>5(
M)*%>9ZG)O_:SLV)NJ3)#%?G;^S\-3N!;@JN"8*G,2YJ7R;D3<'15:\E#IX/R
M!"4A"23DCO3V,DO2X.V&D56IF;8(PR!Y@6(-B+/ 4*@"_G$%04B5T;.,%9BO
M.():QU#=GD_%4$\S+GI-K2:S4,9RT/&J-<OW%JY7;/K)69*85/(N$5)!P5R\
M4(DNY43;D21*0@9VV*5V<J>4=[U=LMTE\B3L7G*I(R5TGF,3&R\\JIB>I.$W
M+UC!-&$0W400629D(Q9H)"BV3.8@JF4,:2 .KX#@<\<CGD<Y&?MU&2>GCOW^
MS/W_ '?;VD)N:W1Y&M>7HW$.W3'%EJV*LN7#$JL[9<V.:K)2DG45&9EWON8*
M%*E;(N&T@T5(!7RY2J&52 Y@3ZS2EQO:LOOJ3/SN9<=U?']FBW$DK'P-5O*E
MYCW\.SC4'3=ZO,*5^ ,T=.'GMC51D#%<$4D$G +G%<4DZW]OV'LHW^Y[O9FE
M[HLA86BD-XF8X]:JU6M8[F(UV]1+7EE9I1U;("5DB.W:3A%LH@FY(T*FQ1,F
MB4YU3&M!:Q4C!8O-!S%I?7:7AZ8YCI2VRC>.:2=B?-8=5)Q,2#2(0:QC9X_4
M*9RN@Q;-VJ9U!*@D1,"E"#@#T[#WY[9^6@R>>>1ZX_AJ->RW>+'[L:G,NY2I
M#C>_U[W7)R5(7E@F/:J=9VQGU.ND-(&91QY"$G&Z3MJHH5H48^5CWC%R('!(
M5/>XMSI:,M5;/<C6:1&%M&)<MY0Q-68)]95&T=;Y*AI,?=;V2F!B#FKZ,XZ?
M$1= FRDRQB915*=V("35;.,*?9<?[1MH6\S%D8ZD[OA3&'NK*-7C0$7.3MOK
M^;D'ERK_ ))0,#F;IQBGN=4,8O4D[:/T/QOM"2(RZ\/"QPEQJ6Y&W5J01E:[
M:MWF9;' R;<P'1?PTXA59.-=$$HB ><S=(G.01ZDCB9(X%.0Q0D@?2(' (]_
M!S@COR/CG0$G&>^,_/MS]_&/X9\[-[I-X]>R=0\126US%);ED>#N%AK2:.X%
MVK&&CJ,2*4GO;WX8U+[(N4LRQ]C2\E4'(F5 3I>6/.>L@9SR?B#:YD3.>4,8
MUR)O6/Z_.6!SCV O*L_"O&T<]*C&D);OD\Q53._9G3<. "$.+-43( "P%\P?
M"98_+YVA_P %&Y;_ /6QYKNO$2_(AW,?P737_P"5KH,$H&.Y&<9R?I$8[^[W
M:<X5SV__ "/Q[M9CRAG:G8;PL^S;?1=-(*/@8>4&+C$_>$O*RT\#-O"UF":B
M*)I&8EY5^UBX]+\44ZRP++F0;IK*IQ9E-RF\RJU9;+-OV=PR.,V;0DU,5&N9
M;)/9S@JR)2+N)-:IDJC>ORLJP9&,[>5B.G?>9#$4:=0+I*"7J=\2*[+;)@J^
MN&+F1J>(\Q[=,HY$;-6QGAR4*M2#5*=D%6A"G%PUB!D&LJ[*)#E2;,U7)P J
M F+-BVYHQ?2<6R6:)ZYP26-(VOGLPVIK(-7D:_B_9A<M1B%D%3$E'<D'0A%L
MF9E7+]VLBU;)G64*08&,#C))/O\ AP,8Y[^_OJ>2!S]8QS\>Q_AKW<%,-K#"
M0T^R1?-V<Y%1\NT;RC%S%R2#:2:(O$$9"->IHO(]\FDL4CMB[22<M5RJ(+ID
M53,4#7R5.S1ETJ]=M\*5^6'M$)%V"*"4CGL1(^[I=DB_9"]BY%%N_CW(MUTQ
M6:.T$G"!Q%-5,IBB&C5.IUZ#1HT:::-8ZRYEK'F"<:W/+V6+3&4O'E @W=AM
M-DEE?*:1\<T*'T2$*!EG;YXN=%C&1K1-9]*23EK'L&[AXY01/["=G86KPDQ9
M;)+1T#7J_&/IJ=FY=XA'Q4/$1;55[(R<D_='2;,V+%HBLY=NG"B:*""1U5#E
M(41#7A>-#XM<WO[R2IB?$DI(Q.TK&DXHI669?/8KY?M3 RK;YRK*T-Y:ON=
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M4,/[SKO)L&HMZ]F".CLJ1/23H1"0EQ6C;8BF)0*03A9HN0DE"!W(241$X?2
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MH)CFIWVL98NV%,K6RT7VRSD[@C<'NASIB=5_.R+J098ES!6,CSC"@$2<O5%
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MK6!11T5W#QEJ*P)86C=--<C4Z<F6,8 N+ANLH3V8GDG2$3]7ZWNBU+)M/L-
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M<")$'UY#G7!%Y;?5VGU*=/:V>9N"4\^XXY5:S>57K$J3]+"'':9(DTE\'H
M8;2ZEI(#2%%"1KMFU+YHLZGPX3NZCM#CM,H0BETFTZ72H\?Z*>M#=18CU-@C
MK)_3K4TIU1+JT@J.//N">'O5#"!#9/R,LGV $3S*""IO3NHH%00$IQ_]H!$
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MT:-&C331HT:---&C1HTTT:-&C331HT:---5^>*?^0)N,_>]5_P"L*H:2,$0
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M C6.?7ZOD_QV^(#W]?ASJV[\( _Y%VN=N?\ '.6.WV^[Z+Q]_P#8-+9?5QP
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MMKFWS:](T/,67H2BVQ;*UOL"4+(QEF>KGAY*,K*#)\"L1"2+0$G"K%T0I!<
MJ443"=,@"43+<E$#% P<"42]11^)@'@>0$._IW#GN'/U<ZYY[\_S_$ 'GU]>
M1 /J[AQ\0#OTWN#85+W&M\VW6)50APS.C3B]35QVY(>B!:4(ZI<>6UY:O-7U
MCRNHD#"@0<\@;7[E5G:FYQ==!ATR?/\ R=+IOD5=N6[$\B8IA3B^B'+A/%U/
MD)\L^?T#*NIM7T2'M,:;^]H&8KO!XWQKFZOVN[V51XE!U]E$6QLYD%&#!U*.
MRI+R-?9,DQ08,G3DWGN4@$B)BD$R@E(:+'C5_D-SOKP.2\;\\?5[W7_M]^E_
M?"I_+YP!]DC=0X^'ZW=L].X^O]@^M@'QJ_R&YW^$O&_]+.-<65/;BC;8[\[7
MT.B3*G-BS)MNU5QVJ.177TR':Y,BJ0VJ)%AMAD-PVE *;4L+4X2LI*4I] J/
MNO7MW_#9O#<=P0*13YD"!=-%:9HS4QF,J,Q;E/FI<<3-FSG2^7)[J5%+J6^A
M#8#84%*5Z[P>_P @K%7[NY)_K L.K.]5B>#W^03BG]W<D_U@6'[]6=ZTCNI^
MTR__ /.%P_[K*UT/LU^R3;+_ "':G^R0M5N[BXZ\5;>#B[,,?@"^9RHT5@2\
M463;4B-JDJM&62;ND%+1XN6UKG(1J4H,(QT)E4E%%2%7*!"F R@!SB.D9'R'
MNQB-PH8(DML^/ZOBBQT&5C+$[J;6Z9>EYR6C'T2><K5*D96/8PE,(Q<.(Q_,
MOE915V[\AHD5H*@(RLSAN+QGM_80"MX=S3^?N$BI$4>ATV"D+;?KO*HD(HX9
M5FKQ*:KU\+5)1-1Z\5%M',B*)>UO$3+(E4Q[CO>5CB[9!B<562H9;PKD*RM7
M3RGUO-M"=T=2ZI,43.'R54E >2<)+/F3<IEW$6223DBI%,8C0X%/TX'SCMZ$
M9Y[>O&<>ON]Y[\ZV3@9[^H/PR,8]/EQGGTUX2*V^QMOWB;D+IE'$]>M5#L>,
M<'PE,G+C6X&P1SN1B&]V1MC.&&21>.&;AJ1[%DD3I)-15!1KPHKY113^S:AC
M_(6W:SY#VXO:Y)R."H)RXO& ,B)E;+M8VLV216<S&);(JFJ#X9VHRRZZ\%(.
M6RGO> <!YKLJS5!KK*>=-T-,P)8:)4IRG94O-GR,UL[ZM0&*J2M=Y=5I4$XM
M6<<.8]L^:.DD6R4NT5\Q-)<@)@L=44BI@)OBQ)NWQCENYJXV3A\DXVR/[F6L
M;"BYAH$YCRPSM?:JD0>R]=3E4SL)QHP64(1\6-?N'+0#>8LW(B4ZA7TB.W!
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M]L'/..,ZLWYMV_\ %U_Z%/\ Y6M0]\TV6/VJLF_Z/K?_ +FT?--EC]JO)O\
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LSP/?@C//J3]78^[UTQR?F#Z>F/Y:-&C1J-3HT:-&FFC1HT:::-&C1IIK_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
